,Sr.No._x,Accord Code_x,Company Name,BS_Share Capital,BS_Share Capital1,FH_Market Capitalization,Gross_Plus_CWIP,long term borrowing,Gross_Plus_CWIP1,long term borrowing1,CAPEX Growth,Debt Growth,Gross_Plus_CWIP_chg,ZSCORE_CAPEX,ZSCORE_DEBTGROWTH,ZSCORE_SHARECAPITAL,ZSCORE_MCAP,Stock Name,NSE Code,BSE Code,Stock Code,ISIN,Industry Name,Current Price,Current Price.1,Market Capitalization,PE TTM Price to Earnings,Forecaster Estimates 1Y forward PE,PE 3Yr Average,PE 5Yr Average,%Days traded below current PE Price to Earnings,Sector PE TTM,Industry PE TTM,PEG TTM PE to Growth,Forecaster Estimates 1Y forward PEG,Sector PEG TTM,Industry PEG TTM,Price to Book Value,%Days traded below current Price to Book Value,Sector Price to Book TTM,Industry Price to Book TTM,Basic EPS TTM,EPS TTM Growth %,ROE Annual %,Sector Return on Equity ROE,Industry Return on Equity ROE,RoA Annual %,Sector Return on Assets,Industry Return on Assets,Piotroski Score,sector_name,Industry Name.1,Latest financial result,Result Announced Date,Sr.No._y,Accord Code_y,FR_Adjusted PE (x),FR_Price / Book Value(x),FR_Dividend Yield(%),FR_EV/Net Sales(x),FR_EV/EBITDA(x),FR_EV/EBIT(x),FR_M Cap / Sales,ZSCORE_PE,ZSCORE_EVEBITDA,ZSCORE_FINAL
0,1,123204,Aban Offshore Ltd.,333.557806,313.556618,1510.23858395,1241.1307019,3082.987916,1189.8713065,1456.3185206,4.30797810821906,111.69736375596,4.307978108219057,-0.5038599668737377,1.8458799389246463,1.4241661642016736,-0.49494754195023943,Aban Offshore Ltd.,ABAN,523204.0,ABAN,INE421A01028,Exploration & Production,39.51,39.51,230.6,-0.24,Export NA,,,,21.32,8.27,-0.01,Export NA,2.03,0.36,-0.01,,1.98,0.96,-166.14,28.61,0.0,13.5,14.29,-86.98,5.84,6.93,4.0,Oil & Gas,Exploration & Production,2024-12-31,2025-02-11,3,123204.0,6.49550117671534,1.64303491739295,0.900788189665958,4.66158135496812,6.11385484472536,7.00249250384848,1.50270519267479,-0.22439819936234626,-0.4868174412802817,0.3831261547962058
2,3,132296,Glenmark Pharmaceuticals Ltd.,25.052,24.8726,3953.2056,302.9307,1065.9073,709.3052,527.6144,-57.2919104498318,102.023921257646,-57.291910449831754,2.015164737977,0.06798167441555908,-0.9388307627687084,-0.013672265453094615,Glenmark Pharmaceuticals Ltd.,GLENMARK,532296.0,GLENMARK,INE935A01035,Pharmaceuticals,1411.0,1411.0,39818.53,-226.45,Export NA,98.84,56.76,,40.48,40.18,-2.87,Export NA,5.74,5.72,4.71,66.34,8.22,8.34,-6.23,79.03,-19.13,16.9,17.11,-10.45,11.67,11.81,2.0,Pharmaceuticals & Biotechnology,Pharmaceuticals,2024-12-31,2025-02-14,98,132296.0,18.1400160938039,3.21406537799077,0.253485424588086,5.85965864038442,13.8984034430253,14.689472382646,4.62601724959488,1.539272023722358,-0.19512524074935567,0.3605433551314514
